Abiopharma

🔍 Morris Arlene (Director)

Company: PALATIN TECHNOLOGIES INC (PTN)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 2,400 shares of Stock Option (Right to Buy) at $21.38 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2035-12-09 | Exercise: 2026-12-09 | equity_swap_involved: 0 | shares_owned_after: 3,527.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,400 shares of Stock Option (Right to Buy) at $21.38 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2035-12-09 | Exercise: 2026-12-09 | equity_swap_involved: 0 | shares_owned_after: 5,927.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9, 2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.
• F2: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.